go back

Lisocabtagene Maraleucel (Breyanzi) CAR-T Therapy

Maryland rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $562,341 · 10th–90th $537,032$562,3410%50%10th$562,341Professionalmedian $562,341 · 10th–90th $562,341$616,5950%50%90th$562,341$50.0K$100.0K$200.0K$500.0K$1.0M$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$537,031.80
Median
$562,341.33
Typical High
$562,341.33
Aetna
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$616,595.00
Cigna
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$676,082.98
Kaiser Permanente
Setting
Professional
Modifier
Global
Typical Low
$478,630.09
Median
$562,341.33
Typical High
$602,559.59
United
Setting
Facility
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$630,957.34
United
Setting
Professional
Modifier
Global
Typical Low
$346,736.85
Median
$562,341.33
Typical High
$831,763.77
Wellpoint
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$741,310.24